Wells Fargo’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Wells Fargo’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.18M	Buy	60,770 +28,482	+88%	+$1.45M	﹤0.01%	2929
2025 Q4	$1.65M	Sell	32,288 -99,025	-75%	-$4.58M	﹤0.01%	3599
2025 Q3	$5.1M	Buy	131,313 +1,972	+2%	+$67.8K	﹤0.01%	2562
2025 Q2	$3.89M	Buy	129,341 +1,181	+0.9%	+$33.8K	﹤0.01%	2663
2025 Q1	$3.65M	Buy	128,160 +1,439	+1%	+$45.5K	﹤0.01%	2663
2024 Q4	$4.19M	Buy	126,721 +334	+0.3%	+$12.6K	﹤0.01%	2570
2024 Q3	$4.72M	Buy	126,387 +1,759	+1%	+$64.1K	﹤0.01%	2387
2024 Q2	$4.19M	Buy	124,628 +44,525	+56%	+$1.49M	﹤0.01%	2397
2024 Q1	$2.86M	Sell	80,103 -467	-0.6%	-$16.2K	﹤0.01%	2691
2023 Q4	$2.65M	Buy	80,570 +30,918	+62%	+$830K	﹤0.01%	2678
2023 Q3	$1.35M	Buy	49,652 +13,791	+38%	+$415K	﹤0.01%	3107
2023 Q2	$1.13M	Buy	35,861 +18,694	+109%	+$581K	﹤0.01%	3384
2023 Q1	$467K	Sell	17,167 -1,557	-8%	-$47K	﹤0.01%	3891
2022 Q4	$569K	Sell	18,724 -1,199	-6%	-$36.1K	﹤0.01%	3564
2022 Q3	$601K	Sell	19,923 -740	-4%	-$23.4K	﹤0.01%	3579
2022 Q2	$572K	Sell	20,663 -129,978	-86%	-$3.71M	﹤0.01%	3661
2022 Q1	$5.07M	Sell	150,641 -56,751	-27%	-$1.97M	﹤0.01%	2449
2021 Q4	$8.76M	Buy	207,392 +10,796	+5%	+$481K	﹤0.01%	1980
2021 Q3	$8.95M	Buy	196,596 +24,625	+14%	+$1.13M	﹤0.01%	2308
2021 Q2	$8.41M	Buy	171,971 +2,082	+1%	+$99.7K	﹤0.01%	2365
2021 Q1	$8.54M	Sell	169,889 -9,459	-5%	-$524K	﹤0.01%	2328
2020 Q4	$9.19M	Buy	179,348 +7,968	+5%	+$379K	﹤0.01%	2152
2020 Q3	$7.05M	Buy	171,380 +11,325	+7%	+$467K	﹤0.01%	2186
2020 Q2	$6.7M	Buy	160,055 +33,494	+26%	+$1.32M	﹤0.01%	2191
2020 Q1	$4.01M	Buy	126,561 +29,687	+31%	+$1.14M	﹤0.01%	2413
2019 Q4	$4.1M	Sell	96,874 -14,374	-13%	-$533K	﹤0.01%	2738
2019 Q3	$3.51M	Buy	111,248 +14,752	+15%	+$519K	﹤0.01%	2861
2019 Q2	$3.49M	Sell	96,496 -6,545	-6%	-$226K	﹤0.01%	2875
2019 Q1	$3.73M	Sell	103,041 -53,875	-34%	-$1.8M	﹤0.01%	2820
2018 Q4	$4.42M	Buy	156,916 +4,632	+3%	+$154K	﹤0.01%	2551
2018 Q3	$6M	Buy	152,284 +12,730	+9%	+$483K	﹤0.01%	2512
2018 Q2	$5.2M	Buy	139,554 +31,551	+29%	+$1.14M	﹤0.01%	2647
2018 Q1	$3.7M	Buy	108,003 +103,045	+2,078%	+$3.61M	﹤0.01%	2873
2017 Q4	$162K	Sell	4,958 -8,574	-63%	-$268K	﹤0.01%	5067
2017 Q3	$422K	Sell	13,532 -86,892	-87%	-$2.55M	﹤0.01%	4434
2017 Q2	$2.8M	Buy	100,424 +6,647	+7%	+$173K	﹤0.01%	2934
2017 Q1	$2.42M	Buy	93,777 +84,714	+935%	+$2.11M	﹤0.01%	3042
2016 Q4	$208K	Sell	9,063 -65,317	-88%	-$1.56M	﹤0.01%	4747
2016 Q3	$1.94M	Buy	74,380 +54,160	+268%	+$1.35M	﹤0.01%	2992
2016 Q2	$458K	Buy	20,220 +4,489	+29%	+$107K	﹤0.01%	3954
2016 Q1	$345K	Sell	15,731 -976	-6%	-$22.3K	﹤0.01%	4090
2015 Q4	$531K	Buy	+16,707	New	+$512K	﹤0.01%	3892

Other funds holding SBIO

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CIS

Connors Investor Services Wyomissing, Pennsylvania $1.08B AUM 31.31% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

MWM

Moran Wealth Management Naples, Florida $3.27B AUM 25.8% 1-Year Est. Return

SFS

Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return

Wells Fargo's SBIO Position: Q1 2026 in Review

Wells Fargo increased its ALPS Medical Breakthroughs ETF (SBIO) stake by 88% in Q1 2026, buying an estimated $1.45M and bringing the position to 60,770 shares worth $3.18M. The position accounts for ﹤0.01% of the portfolio, ranked #2929.

Wells Fargo first reported a position in SBIO in Q4 2015 and has held it in 42 quarters since. The position peaked at $9.19M in Q4 2020. 59 funds tracked by Wall St. Rank hold SBIO as of Q1 2026.

Wells Fargo held 60,770 shares of ALPS Medical Breakthroughs ETF worth $3.18M as of Q1 2026.
Wells Fargo bought 28,482 ALPS Medical Breakthroughs ETF shares in Q1 2026, an estimated $1.45M.
ALPS Medical Breakthroughs ETF made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #2929 holding.
Wells Fargo first reported a position in ALPS Medical Breakthroughs ETF in Q4 2015 and has held it in 42 quarters since.
Wells Fargo's ALPS Medical Breakthroughs ETF position peaked at $9.19M in Q4 2020.
59 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.